Company Name: |
ChemStrong Scientific Co.,Ltd
|
Tel: |
0755-0755-66853366 13670046396 |
Email: |
sales@chem-strong.com |
Products Intro: |
Product Name:Cinacalcet Impurity 128 CAS:2059891-97-1 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
Shanghai Kewel Chemical Co., Ltd.
|
Tel: |
021-64609169 18901607656 |
Email: |
greensnown@163.com |
Products Intro: |
Product Name:Cinacalcet Impurity 128 CAS:2059891-97-1 Purity:95+ HPLC; Package:10mg;25mg;50mg;100mg
|
Company Name: |
Jinan blalong chemical co. LTD
|
Tel: |
2710913286@.com |
Email: |
1513643261@qq.com |
Products Intro: |
Product Name:CicalcetImpurity35 CAS:2059891-97-1 Purity:99% HPLC Package:50G;10G;1G;500MG;100MG
|
|
| SEVZPXQQXHZTBG-JKSUJKDBSA-N Basic information |
Product Name: | SEVZPXQQXHZTBG-JKSUJKDBSA-N | Synonyms: | Cinacalcet Impurity 15 HCl;1-Naphthalenemethanamine, α-methyl-N-[(2R)-2-[3-(trifluoromethyl)phenyl]propyl]-, (αR)-;(2S)-2-(3-(Trifluoromethyl)phenyl)-N-((R)-1-(naphthalen-1-yl)ethyl)propan-1-amine;Cinacalcet Impurity 128;Cinacalcet Diastereo isomer-1;(R)-N-((R)-1-(naphthalen-1-yl)ethyl)-2-(3-(trifluoromethyl)phenyl)propan-1-amineQ: What is
(R)-N-((R)-1-(naphthalen-1-yl)ethyl)-2-(3-(trifluoromethyl)phenyl)propan-1-amine Q: What is the CAS Number of
(R)-N-((R)-1-(naphthalen-1-yl)ethyl)-2-(3-(trifluoromethyl)phenyl)propan-1-amine;CicalcetImpurity15HCl;CicalcetImpurity35 | CAS: | 2059891-97-1 | MF: | C22H22F3N | MW: | 357.41 | EINECS: | | Product Categories: | | Mol File: | 2059891-97-1.mol | ![SEVZPXQQXHZTBG-JKSUJKDBSA-N Structure](CAS/20210305/GIF/2059891-97-1.gif) |
| SEVZPXQQXHZTBG-JKSUJKDBSA-N Chemical Properties |
Boiling point | 423.8±40.0 °C(Predicted) | density | 1.151±0.06 g/cm3(Predicted) | pka | 8.81±0.38(Predicted) |
| SEVZPXQQXHZTBG-JKSUJKDBSA-N Usage And Synthesis |
Uses | (2S)-2-(3-(Trifluoromethyl)phenyl)-N-((R)-1-(naphthalen-1-yl)ethyl)propan-1-amine, is an impurity of Cinacalcet (C441790), the first calcimimetic drug approved by the United States Food and Drug Administration for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease. |
| SEVZPXQQXHZTBG-JKSUJKDBSA-N Preparation Products And Raw materials |
|